Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Invasive Early Breast Cancer × exemestane × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Neoplasm Metastasis 3 Obesity 2 Arthralgia 2 Vitamin D Deficiency 1 Recurrence 1 Post Menopausal Women With Early Breast Cancer 1 Pain 1 Nutrition Disorders 1 Multiple Endocrine Neoplasia Type 1 1 Invasive Early Breast Cancer 1 Breast Cancer Organoids 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01121549 2014-01-22

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

Pfizer

378 enrolled 16 charts

Invasive Early Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡